Recap: PTC Therapeutics Q4 Earnings

PTC Therapeutics PTCT reported its Q4 earnings results on Tuesday, February 22, 2022 at 04:00 PM.

Here's what investors need to know about the announcement.

Earnings

PTC Therapeutics missed estimated earnings by 23.78%, reporting an EPS of $-2.03 versus an estimate of $-1.64.

Revenue was up $46.36 million from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.49 which was followed by a 4.09% increase in the share price the next day.

Here's a look at PTC Therapeutics's past performance:

 

Quarter Q3 2021 Q2 2021 Q1 2021 Q4 2020
EPS Estimate -1.40 -1.82 -1.51 -0.94
EPS Actual -1.89 -1.68 -1.83 -1.08
Revenue Estimate 126.44M 110.50M 98.80M 111.36M
Revenue Actual 138.74M 116.68M 117.94M 118.86M

To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: EarningsBZI-Recaps
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!